# Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents

> **NCT02684708** · PHASE3 · COMPLETED · sponsor: **University of Giessen** · enrollment: 2921 (actual)

## Conditions studied

- Classical Hodgkin Lymphoma

## Interventions

- **DRUG:** cyclophosphamide, vincristine, prednisone, dacarbazine
- **DRUG:** cyclo, vcr, pred, dacarb,etop and doxo

## Key facts

- **NCT ID:** NCT02684708
- **Lead sponsor:** University of Giessen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 2921 (ACTUAL)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02684708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02684708, "Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02684708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*